CADTH Health Economics Guidelines: What’s New?

Concurrent Session C7 — Panel Discussion

Panellists: Karen Lee, Director, Health Economics, CADTH; Prof. Stirling Bryan, Professor, School of Population and Public Health, University of British Columbia and Director, Centre for Clinical Epidemiology & Evaluation, Vancouver Coastal Health Research Institute; Prof. Doug Coyle, Professor, School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa; Dr. Murray Krahn, Program Director/Senior Scientist, Toronto Health Economics and Technology Assessment (THETA) Collaborative; Prof. Christopher McCabe, Research Director, Capital Health Research Endowed Chair, Department of Emergency Medicine, Adjunct Professor, Department of Economics, and Adjunct Professor, School of Public Health, University of Alberta; Elizabeth McCarron, Health Economist, CADTH

On March 28, 2017, CADTH launched the fourth edition of its influential Guidelines for the Economic Evaluation of Health Technologies — the first update since 2006. Because the Guidelines are used by Canadian health care decision-makers to inform decisions about which drugs, medical devices, and procedures to reimburse, they affect the lives of virtually all Canadians. The Guidelines enable CADTH to provide decision-makers with reliable, consistent, and relevant economic information based on the best practices for determining the comparative value of health technologies. In this session, the members of the Health Economics Working Group will provide insight on key changes to the fourth edition, highlighting why these changes were made and why they are important.

Documents: